2014
DOI: 10.1016/j.ajme.2013.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0
1

Year Published

2015
2015
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 46 publications
0
2
0
1
Order By: Relevance
“…Many of them try to look equality in terms of funding and in this case a difference has to be made in the distribution of costs among those who currently receive health services and the largest group of all those who pay for them. 9 But when we talk about equity in health care, we are focused only on achieving equality in health level, as well as in obtaining health care services.…”
Section: On the Concept Of Equality In Health Carementioning
confidence: 99%
See 1 more Smart Citation
“…Many of them try to look equality in terms of funding and in this case a difference has to be made in the distribution of costs among those who currently receive health services and the largest group of all those who pay for them. 9 But when we talk about equity in health care, we are focused only on achieving equality in health level, as well as in obtaining health care services.…”
Section: On the Concept Of Equality In Health Carementioning
confidence: 99%
“…International Conference on Primary Health Care(1978). Declaration of Alma-Ata 9. Robert B & Leanna S, The Measurement of Equity in School Finance (Baltimore: The Johns Hopkins University Press, 1984) 10.…”
mentioning
confidence: 99%
“…З метою забезпечення раціо-нального використання бюдже-ту системи охорони здоров'я та окремих пацієнтів доцільним є проведення клініко-економіч-ного аналізу фармакотерапії за-хворювань, що дозволить одно-часно оцінити раціональне ви-користання як грошових кош-тів платників за медичну допо-могу, так і ЛП [6][7][8][10][11][12][13]. В умо-вах впровадження в Україні фор-мулярної системи (ФС) резуль-тати клініко-економічного ана-лізу набувають особливої важ-ливості для вітчизняної систе-ми охорони здоров'я, тому що допомагають оцінити якість при-значеної фармакотерапії в за-кладах охорони здоров'я (ЗОЗ) та амбулаторно.…”
unclassified